FEATURED

Drug Showcase: IXEMPRA (ixabepilone)

Indicated for metastatic or locally advanced breast cancer.

The “Antigocoagulation GI Stress Test”

The test could represent a previously under-recognized modality leading to the early detection of a GI malignancy.

Early Breast Cancer Standard of Care

Despite a decade-old approval, which women with early-stage disease might benefit most from treatment.

RCC: A Year in Review

Toni K. Choueiri, MD, delivered a keynote lecture on recent advances in the treatment of renal cell carcinoma at the 2015 GU Symposium.

Crizotinib, ALK-Rearranged NSCLC w/ Brain Metastases

A retrospective analysis of crizotinib data demonstrates control in advanced, metastatic disease, although brain metastases continued to progress.

Intraperitoneal Sarcoma: Role of Chemo

FDCS is very uncommon and is associated with a particularly aggressive clinical course.everal new therapies.

PSA Screening Guidelines: A Middle Ground?

Some researchers are looking at the evidence and urging for a middle ground in prostate cancer screening guidelines

Urea-Based Cream & Sorafenib Skin Reactions

Onset of sorafenib-associated hand-foot skin reactions can be delayed by urea-based cream plus best supportive care in advanced hepatocellular carcinoma.

Metformin and Lung Cancer Risk

A large, retrospective cohort study found no evidence that metformin prevents lung cancer, although nonsmokers may find some benefit.

Looking for a Job?

Access our job board to view over 1,​200 job openings throughout the US.

Treatment Regimens

A full listing of cancer treatment and drug information is available to access.

Viewpoints

Paclitaxel, Trastuzumab New Standard of Care for Early-Stage Breast Cancer

Paclitaxel, Trastuzumab New Standard of Care for Early-Stage Breast Cancer

Trastuzumab has been approved for nearly a decade, but it is still unclear which women with early-stage disease might benefit most from treatment.

Crizotinib Provides Benefit for ALK-Rearranged NSCLC with Brain Metastases

Crizotinib Provides Benefit for ALK-Rearranged NSCLC with Brain Metastases

A retrospective analysis of crizotinib data demonstrates control in advanced, metastatic disease, although brain metastases continued to progress.

Feature Articles

Anticoagulants and Gastrointestinal Cancer Detection

Anticoagulants and Gastrointestinal Cancer Detection

The "antigocoagulation gastrointestinal stress test" could represent a previously under-recognized modality leading to early detection of GI malignancy.

Renal Cell Cancer: Keynote Lecture From GU Symposium 2015

Renal Cell Cancer: Keynote Lecture From GU Symposium 2015

Toni K. Choueiri, MD, delivered a keynote lecture on recent advances in the treatment of renal cell carcinoma at the 2015 GU Symposium.

Featured Videos

Fall Digital Issue

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs